In the case of a high upper outer quadrant early stage breast cancer without adverse histological factors, would you omit boosting the breast lumpectomy cavity if the treatment area would involve a significant portion of axilla due to risk of lymphedema?
Assume the patient had axillary lymph node dissection and taxane chemotherapy. How would you counsel the patient about risk of lymphedema?